Gregory Bowles
Chief Executive Officer at Aquyre Biosciences, Inc.
Profile
Gregory Bowles is the founder of FlexDex, Inc. He is currently the President, Chief Executive Officer & Director at Aquyre Biosciences, Inc. He has previously worked as a Sales Representative at Johnson & Johnson, Sales Manager-Michigan Area at Intuitive Surgical, Inc., Vice President-Sales at EndoGastric Solutions, Inc., and Cryptologist at United States Navy (District of Columbia).
He completed his undergraduate degree at Northwood University (Michigan).
Gregory Bowles active positions
| Companies | Position | Start |
|---|---|---|
Aquyre Biosciences, Inc.
 Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Chief Executive Officer | 04/12/2023 |
Former positions of Gregory Bowles
| Companies | Position | End |
|---|---|---|
FlexDex, Inc.
 FlexDex, Inc. Medical SpecialtiesHealth Technology FlexDex, Inc. engages in the provision of robotic surgery. It engages in research of parallel kinematics, virtual center of rotation, and flexure mechanisms at the school’s precision systems design lab. The firm enhances the capabilities of all MIS instruments and endoscopes. The company was founded by James D. Geiger, Shorya Awtar and Gregory Bowles and is headquartered in Brighton, MI. | Founder | 31/12/2019 |
| United States Navy (District of Columbia) | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Sales & Marketing | - |
| INTUITIVE SURGICAL, INC. | Sales & Marketing | - |
EndoGastric Solutions, Inc.
 EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Sales & Marketing | - |
Training of Gregory Bowles
| Northwood University (Michigan) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| INTUITIVE SURGICAL, INC. | Health Technology |
| Private companies | 4 |
|---|---|
EndoGastric Solutions, Inc.
EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Health Technology |
FlexDex, Inc.
FlexDex, Inc. Medical SpecialtiesHealth Technology FlexDex, Inc. engages in the provision of robotic surgery. It engages in research of parallel kinematics, virtual center of rotation, and flexure mechanisms at the school’s precision systems design lab. The firm enhances the capabilities of all MIS instruments and endoscopes. The company was founded by James D. Geiger, Shorya Awtar and Gregory Bowles and is headquartered in Brighton, MI. | Health Technology |
| United States Navy (District of Columbia) | Government |
Aquyre Biosciences, Inc.
Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Health Services |
- Stock Market
- Insiders
- Gregory Bowles
